Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey

J Prev Med Public Health. 2022 May;55(3):263-272. doi: 10.3961/jpmph.21.573. Epub 2022 May 20.

Abstract

Objectives: Infections with hepatitis B, C, and D virus (HBV, HCV, and HDV) are a major public health problem and lead to serious complications such as cirrhosis and hepatocellular carcinoma. We aimed to determine the seroprevalence of hepatitis B surface antigen (HBsAg), anti-HCV, anti-HDV immunoglobulin G, alpha-fetoprotein (AFP), and dual and triple hepatitis virus infections in Mongolia.

Methods: A total of 2313 participants from urban and rural regions were randomly recruited for this cross-sectional study. A questionnaire was used to identify the risk factors for hepatitis virus infections, and the seromarkers were measured using immunoassay kits.

Results: Among all participants, the prevalence of HBV, HCV, and HDV was 15.6%, 36.6%, and 14.3%, respectively. The infection rates were significantly higher in females and participants with a lower education level, rural residence, older age, and a history of blood transfusion. HBV and HCV co-infection was found in 120 (5.2%) participants and HBV, HCV, and HDV triple infection was detected in 67 (2.9%) participants. The prevalence of elevated AFP was 2.7%, 5.5%, and 2.6% higher in participants who were seropositive for HBsAg (p=0.01), anti-HCV (p<0.001), and anti-HDV (p=0.022), respectively. Elevated AFP was more prevalent in participants co-infected with HBV and HCV (5.8%, p=0.023), HBV and HDV (6.0%, p<0.001), and triple-infected with HBV, HCV, and HDV (7.5%) than in uninfected individuals.

Conclusions: Nearly half (49.8%) of the study population aged ≥40 years were infected with HBV, HCV, or HDV, and 22.4% had dual or triple infections.

Keywords: Alpha-fetoprotein; Epidemiology; Hepatitis B; Hepatitis C; Hepatitis D; Mongolia.

MeSH terms

  • Aged
  • Biomarkers, Tumor
  • Cross-Sectional Studies
  • Female
  • Hepatitis Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B virus
  • Hepatitis B* / complications
  • Hepatitis B* / epidemiology
  • Hepatitis C Antibodies
  • Hepatitis C* / complications
  • Hepatitis C* / epidemiology
  • Hepatitis Delta Virus
  • Humans
  • Mongolia / epidemiology
  • Prevalence
  • Seroepidemiologic Studies
  • Surveys and Questionnaires
  • Virus Diseases* / complications
  • alpha-Fetoproteins

Substances

  • Biomarkers, Tumor
  • Hepatitis Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies
  • alpha-Fetoproteins

Grants and funding